Impact of adalimumab on rheumatoid arthritis (RA) outcomes: Comparison of an open-label extension study and a registry-based control group

被引：0
|
作者：
Halpern, M. T. [1 ]
Citaldi, M. [2 ]
Kvien, T. [3 ]
机构：
[1] Emory Univ, Dept Hlth Policy & Management, Atlanta, GA 30322 USA
[2] Abbott Labs, Global Hlth Econ & Outcomes Res, Abbott Pk, IL 60064 USA
[3] Diakonjemmet Hosp, Dept Rheumatol, Oslo, Norway
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2007年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：171 / 171
页数：1
相关论文
共 50 条
  • [31] A Multicenter, Randomized, Controlled, Open-Label Pilot Study of the Feasibility of Discontinuation of Adalimumab in Rheumatoid Arthritis Patients in Stable Clinical Remission.
    Chatzidionysiou, Katerina
    Turesson, Carl
    Teleman, Annika
    Knight, Ann
    Lindqvist, Elisabet
    Larsson, Per
    Coster, Lars
    Rydberg, Barbro
    van Vollenhoven, Ronald F.
    Heimburger, Mikael
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S336 - S336
  • [32] Clinical Outcomes for Rheumatoid Arthritis Patients Receiving Tofacitinib Monotherapy in the Open-Label Long-Term Extension over 6 Years
    Fleischmann, Roy
    Yazici, Yusuf
    Wollenhaupt, Juergen
    Wang, Lisy
    Maniccia, Anna
    Kwok, Kenneth
    Takiya, Liza
    van Vollenhoven, Ronald
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [33] SARILUMAB DOSE REDUCTION TO MANAGE LABORATORY ABNORMALITIES IN AN OPEN-LABEL EXTENSION STUDY IN RA PATIENTS
    Genovese, M. C.
    Fay, J.
    Parrino, J.
    Garg, A.
    Van Hoogstraten, H.
    Boddy, A.
    Martincova, R.
    Graham, N.
    Simon, J.
    Burmester, G. R.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 515 - 516
  • [34] Sarilumab Dose Reduction to Manage Laboratory Abnormalities in an Open-Label Extension Study in RA Patients
    Burmester, Gerd
    Garg, Anju
    van Hoogstraten, Hubert
    Graham, Neil
    Boddy, Alex
    Parrino, Janie
    Genovese, Mark C.
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [35] SARILUMAB DOSE REDUCTION TO MANAGE LABORATORY ABNORMALITIES IN AN OPEN-LABEL EXTENSION STUDY IN RA PATIENTS
    Burmester, Gerd R.
    Garg, Anju
    Van Hoogstraten, Hubert
    Graham, Neil
    Boddy, Alexander
    Parrino, Janie
    Genovese, Mark C.
    INTERNAL MEDICINE JOURNAL, 2016, 46 : 40 - 41
  • [36] Safety and Efficacy of Baricitinib through 128 Weeks in an Open-Label, Long- Term Extension Study in Patients with Rheumatoid Arthritis
    Magloire, Annaise
    Keystone, Edward
    Taylor, Peter
    Genovese, Mark
    Schlichting, Douglas
    de la Torre, Inmaculada
    Beattie, Scott
    Rooney, Terence
    SWISS MEDICAL WEEKLY, 2015, 145 : 4S - 5S
  • [37] Clinical response and tolerability to abatacept in patients with rheumatoid arthritis previously treated with infliximab or abatacept: open-label extension of the ATTEST Study
    Schiff, Michael
    Keiserman, Mauro
    Codding, Christine
    Songcharoen, Suthin
    Berman, Alberto
    Nayiager, Sauithree
    Saldate, Cristina
    Aranda, Richard
    Becker, Jean-Claude
    Nys, Marleen
    Le Bars, Manuela
    Reed, Diane Moniz
    Poncet, Coralie
    Dougados, Maxime
    ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (11) : 2003 - 2007
  • [38] Adalimumab (Humira®) plus methotrexate in patients with rheumatoid arthritis:: Continued efficacy up to 4 years in open-label trials
    Schiff, MH
    Weisman, M
    Furst, DE
    Kavanaugh, A
    Spencer-Green, G
    Perez, JL
    Segurado, OG
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 269 - 269
  • [39] Safety and Efficacy of Baricitinib through 128 Weeks in an Open-Label, Long-Term Extension Study in Patients with Rheumatoid Arthritis
    Keystone, Ed
    Taylor, Peter
    Genovese, Mark
    Schlichting, Douglas
    de la Torre, Inmaculada
    Beattie, Scott
    Rooney, Terence
    JOURNAL OF RHEUMATOLOGY, 2015, 42 (07) : 1292 - 1292
  • [40] SAFETY AND EFFICACY OF BARICITINIB THROUGH 128 WEEKS IN AN OPEN-LABEL, LONG-TERM EXTENSION STUDY IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Keystone, E.
    Taylor, P.
    Genovese, M.
    Schlichting, D.
    De La Torre, I
    Beattie, S.
    Rooney, T.
    Suters, A.
    INTERNAL MEDICINE JOURNAL, 2015, 45 : 26 - 26
12345